vTv Therapeutics (VTVT) Minority Interest (2014 - 2025)

vTv Therapeutics has disclosed Minority Interest across 12 years of filings, most recently posting -$357000.0 for Q2 2025.

• In Q2 2025, Minority Interest fell 109.01% year-over-year to -$357000.0; the TTM figure through Jun 2025 stood at -$357000.0 (down 109.01% YoY), while the FY2024 annual figure was $2.1 million, down 65.72% from the prior year.
• Minority Interest came in at -$357000.0 for Q2 2025 at vTv Therapeutics, down from $977000.0 in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $62.6 million in Q1 2021 to a low of -$357000.0 in Q2 2025.
• Average Minority Interest over 5 years is $18.5 million, with a median of $15.1 million recorded in 2022.
• Year-over-year, Minority Interest soared 36.42% in 2023 and tumbled 109.01% in 2025.
• Over 5 years, Minority Interest stood at $25.0 million in 2021, then sank by 33.58% to $16.6 million in 2022, then slumped by 63.02% to $6.1 million in 2023, then plunged by 65.72% to $2.1 million in 2024, then sank by 116.98% to -$357000.0 in 2025.
• Per Business Quant data, the three most recent Minority Interest figures were -$357000.0 in Q2 2025, $977000.0 in Q1 2025, and $2.1 million in Q4 2024.